Ginkgo diterpene lactone meglumine injection
No.2020-134
Phase 3 small_molecule active
Quick answer
Ginkgo diterpene lactone meglumine injection for Ischemic Stroke, Acute is a Phase 3 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- Ischemic Stroke, Acute
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active